Platelet–larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization

Heart and Vessels

Volumn 30, Issue 1, 2015, Pages 20-27

  Verdoia, Monica ^a   Barbieri, Lucia ^a   Schaffer, Alon ^a   Cassetti, Ettore ^a   Marino, Paolo ^a   Bellomo, Giorgio ^a   Sinigaglia, Fabiola ^a   De Luca, Giuseppe ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Percutaneous coronary intervention; Periprocedural myocardial infarction; Platelets; Platelet larger cell ratio

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATINE KINASE MB; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET LARGER CELL RATIO; PLATELET REACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; ADVERSE EFFECTS; ANGIOCARDIOGRAPHY; BLOOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE PERIOD; REGRESSION ANALYSIS; RISK; RISK FACTOR; STENT;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PLATELET COUNT; REGRESSION ANALYSIS; RISK FACTORS; STENTS; TROPONIN I;

EID: 84928639498     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-013-0449-4     Document Type: Article

References (46)

1. Baber U, Kini AS, Sharma SK (2010) Stenting of complex lesions: an overview. Nat Rev Cardiol 7(9):485–496
2. De Luca G, Bellandi F, Huber K, Noc M, Petronio AS, Arntz HR, Maioli M, Gabriel HM, Zorman S, De Carlo M, Rakowski T, Gyongyosi M, Dudek D (2011) Early glycoprotein IIb–IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient’s data meta-analysis. J Thromb Haemost 9:2361–2370
3. De Luca G, Smit JJ, Ernst N, Suryapranata H, Ottervanger JP, Hoorntje JC, Dambrink JH, Gosslink AT, de Boer MJ, van’t Hof AW (2005) Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost 9(93):820–823
4. De Luca G, Cassetti E, Verdoia M, Marino P (2009) Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analysis of randomised trials. Thromb Haemost 102:428–436
5. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F (2008) Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 29:3002–3010
6. Di Lorenzo E, De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G (2009) The PASEO (paclitaxel or sirolimus-eluting stent versus bare metal stent in primary angioplasty) randomized trial. JACC Cardiovasc Interv 2:515–523
7. De Luca G, Van’t Hof AW, Huber K, Gibson CM, Bellandi F, Arntz HR, Maioli M, Noc M, Zorman S, Secco GG, Zeymer U, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Dudek D (2013) Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb–IIIa inhibitors. Heart Vessels. doi:10.1007/s00380-013-0323-4
8. Califf RM, Abdelmeguid AE, Kuntz RE, Popma J, Davidson CJ, Koen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Barman RP, Zuckerman BD, Chaitman BR, Bitti JA, Magnus Ohman E (1998) Myonecrosis after revascularization procedures. J Am Coll Cardiol 31:241–251
9. De Luca G, Suryapranata H, Chiariello M (2006) Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction. A review of current status. Thromb Haemost 96:700–710
10. Herrmann J (2005) Peri-procedural myocardial injury: 2005 update. EurHeart J 26:2493–2519
11. Michaels AD, Gibson CM, Barron HV (2000) Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 85:50b–60b
12. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP (2003) Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9:177–190
13. Martin JF, Trowbridge EA, Salmon G, Plumb J (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460
14. Pizzulli L, Yang A, Martin JF, Luderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 19(1):80–84
15. Greisenegger S, Endler G, Hsieh H, Tentschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 35:1688–1691
16. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G (2004) Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 15:475–478
17. Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G (2005) Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 46(2):284–290
18. Goncalves SC, Labinaz M, Le May M, Glover C, Froeschl M, Marquis JF, O’Brien E, Shukla D, Ruchin P, Sookur D, Ha A, So D (2011) Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol 107(2):204–209
19. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A, Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A (2007) Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 120:245–250
20. Halbmayer WM, Haushofer A, Radek J, Schön R, Deutsch M, Fischer M (1995) Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Coron Artery Dis 6(5):397–402
21. Grotto HZW, Noronha JFA (2004) Platelet larger cell ratio (P-LCR) in patients with dyslipidemia. Clin Lab Haem 26:347–349
22. Morris MW, Davey FR (2001) Basic examination of blood. In: Henry JB (ed) Clinical diagnosis and management by laboratory methods. Saunders, pp 451–479
23. Bessman JD, Williams LJ, Gilmer PR (1981) Mean platelet volume: the inverse relation of platelet size and count in normal subjects and an artifact of other particles. Am J Clin Pathol 76:289–293
24. De Luca G, Secco GG, Santagostino M, Venegoni L, Iorio S, Cassetti E, Verdoia M, Coppo L, Di Mario C, Bellomo G, Marino P (2012) Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 22:426–433
25. Cuculi F, Lim CC, Banning AP (2010) Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented? Heart 96(10):736–740 Review
26. Arai T, Yuasa S, Miyata H, Kawamura A, Maekawa Y, Ishikawa S, Noma S, Inoue S, Sato Y, Kohsaka S, Fukuda K (2012) Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry. Heart Vessels. doi:10.1007/s00380-012-0314-x
27. Hanna EB, Hennebry TA (2010) Periprocedural myocardial infarction: review and classification. Clin Cardiol 33(8):476–483 Review
28. Duygu H, Turkoglu C, Kirilmaz B, Turk U (2008) Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris. J Invasive Cardiol 20(3):120–124
29. Topol EJ, Yadav JS (2000) Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101:570–580
30. Gach O, Louis O, Chapelle JP, Vanbelle S, Pierard LA, Legrand V (2009) Vaseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart Vessels 24(4):267–270
31. Kamath S, Blann AD, Lip GY (2001) Platelet activation: assessment and quantification. Eur Heart J 22:1561–1571
32. Park Y, Schoene N, Harris W (2002) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 13(5–6):301–306
33. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I (2010) Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 14(1):28–32
34. Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK (2006) Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 59(2):146–149
35. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47–58
36. Kanbay A, Tutar N, Kaya E, Buyukoglan H, Ozdogan N, Oymak FS, Gulmez I, Demir R (2013) Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovascular diseases. Blood Coagul Fibrinolysis 24(5):532–536
37. De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Coppo L, Schaffer A, Fundaliotis A, Iorio S, Venegoni L, Bellomo G, Marino P (2010) Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study. J Thromb Thrombolysis 30:426–433
38. Lippi G, Meschi T, Borghi L (2012) Mean platelet volume increases with aging in a large population study. Thromb Res 129(4):e159–e160
39. Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, Singh S (2011) Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology 16(2):86–89
40. Smith NM, Pathansali R, Bath PM (2002) Altered megakaryocyte–platelet–haemostatic axis in patients with acute stroke. Platelets 13:113–120
41. Senaran H, Ileri M, Altinbas A, Kosar A, Yetkin E, Ozturk M, Karaaslan Y, Kirazil S (2001) Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 24:405–408
42. Beyan C, Kaptan K, Ifran A (2006) Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers. J Thromb Thrombolysis 22(3):161–164
43. Jagroop IA, Mikhailidis DP (2000) Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 14(9):581–585
44. Sato Y, Fujii S, Imagawa S, Ohmura K, Ohmura Y, Andoh Y, Dong J, Ishimori N, Furumoto T, Tsutsui H (2007) Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers. J Atheroscler Thromb 14(1):31–35
45. Zhang F, Dong L, Ge J (2010) Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis. Ann Med 42(3):171–177
46. Sardella G, Conti G, Donahue M, Mancone M, Canali E, De Carlo C, Di Roma A, Calcagno S, Lucisano L, Fedele F (2013) Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial. Catheter Cardiovasc Interv 81(1):E36–E43